HPHA.DE
Heidelberg Pharma AG
Price:  
3.45 
EUR
Volume:  
14,365
Germany | Biotechnology

HPHA.DE Gross Margin

As of 2025-05-29, the Gross Margin of Heidelberg Pharma AG (HPHA.DE) is 74%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

HPHA.DE Gross Margin - Historical Value
DateValue
2024-11-30 74%
2023-11-30 67%
2022-11-30 74.7%
2021-11-30 -169.3%
2020-11-30 34%
2019-11-30 48.9%
2018-11-30 39.8%
2017-11-30 49.7%
2016-11-30 40.6%
2015-11-30 50.1%
HPHA.DE Gross Margin - Peers Comparison